Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Launched by DL ANALYTICS · Feb 4, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new screening test called Automated Visual Evaluation (AVE) to help detect cervical cancer early. The specific version being tested is called CINFinder, and it uses artificial intelligence to analyze digital images of the cervix. The goal is to see if this low-cost, lab-free method can effectively screen for cervical cancer and help identify women who may need further testing. This could be a game changer for many women around the world, as it may make cervical cancer screening more accessible.

To participate in this study, women between the ages of 30 and 59 who have not had certain medical conditions or treatments in the last five years may be eligible. It's important to note that women who are pregnant, have had a hysterectomy, or have previously been diagnosed or treated for cervical cancer in that time frame cannot join. If eligible, participants can expect to undergo a colposcopy, a procedure that allows doctors to closely examine the cervix, while contributing to important research that could improve cervical cancer screening in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women between 30 and 59 years of age
• Exclusion Criteria:
• • Pregnancy at the time of colposcopy/biopsy
• • Hysterectomy with surgically absent cervix
• • HPV test in the last 5 years independently of negative or positive result
• • Previous cervical cancer diagnosis or treatment in the last 5 years
• • Lack of willingness or capacity to provide informed consent